Does Rallies show 13F holders for ARDX?

Yes. Rallies tracks hedge fund and 13F ownership data for ARDX, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ARDX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ARDX. It does not provide personalized investment advice.

ARDX (Ardelyx, Inc.) Stock Analysis - Hedge Fund Holdings

Ardelyx, Inc. (ARDX) is a publicly traded Healthcare sector company. As of May 21, 2026, ARDX trades at $6.26 with a market cap of $1.51B and a P/E ratio of -24.10. ARDX moved +2.79% today. Year to date, ARDX is +2.96%; over the trailing twelve months it is +50.00%. Its 52-week range spans $3.21 to $8.40. Analyst consensus is strong buy with an average price target of $16.60. Rallies surfaces ARDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ARDX stock?

Hedge funds tracked by Rallies that own ARDX include Redmile Group, Panagora Asset, and Farallon Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Ardelyx, Inc..

ARDX Key Metrics

Key financial metrics for ARDX
Metric	Value
Price	$6.26
Market Cap	$1.51B
P/E Ratio	-24.10
EPS	$-0.26
Dividend Yield	0.00%
52-Week High	$8.40
52-Week Low	$3.21
Volume	109
Avg Volume	0
Revenue (TTM)	$407.32M
Net Income	$-61.60M
Gross Margin	90.29%

Top Hedge Funds Holding ARDX

Redmile Group holds 733.35K shares of ARDX, changed -53.48% as of Mar 31, 2026.
Panagora Asset holds 659.16K shares of ARDX, changed -0.08% as of Dec 31, 2025.
Farallon Capital holds 23.00K shares of ARDX, changed +0.00% as of Mar 31, 2026.

Latest ARDX News

Ardelyx Q1 Revenue Up 38% to $93.4M; IBSRELA Sales Reach $70.1M — Apr 30, 2026
Ardelyx Secures DDW IBS-C Poster Slot and Faces Potential Negative Earnings — Apr 23, 2026
Ardelyx Launches Multi-Year LPGA Partnership to Educate on IBS-C — Feb 24, 2026
Ardelyx Reports 73% IBSRELA Sales Surge, Guides 50% Revenue Rise, Stock Slides — Feb 20, 2026
Ardelyx Posts 73% IBSRELA Revenue Growth, XPHOZAH Dispenses Up 9% — Feb 20, 2026

Recent ARDX Insider Trades

RAAB MICHAEL sold 41.67K (~$261.95K) on Apr 15, 2026.
RAAB MICHAEL sold 41.67K (~$243.33K) on Mar 16, 2026.
RAAB MICHAEL sold 41.67K (~$260.62K) on Feb 24, 2026.

ARDX Analyst Consensus

5 analysts cover ARDX: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.60.

Common questions about ARDX

Who owns ARDX stock?: Hedge funds tracked by Rallies that own ARDX include Redmile Group, Panagora Asset, and Farallon Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Ardelyx, Inc..
Does Rallies show 13F holders for ARDX?: Yes. Rallies tracks hedge fund and 13F ownership data for ARDX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ARDX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ARDX. It does not provide personalized investment advice.